Ann: Trading Halt, page-94

there is a lot of counting chickens going on here. Not that I am not doing it either but I hope we get what we're looking for. From both the scientific perspective (for the patients), and a financial perspective.

I have to say I'm very anxious about this afternoon's webinar. I sat through the trading halt when Elanco pulled the deal on their option. Then sat and watched the share price go backwards to a small number. 

that's almost 4 years ago. This does feel different, though. MT looks pretty bullish and excited. Surely, this must be ok news at worst. 

Someone asked why they weren't also focusing on the other central nervous system disorders. This path gives us the option for accelerated approval because MND is a rare disease. once that happens, then the other diseases can be looked into. 

vacuum cleaner for toxic protein buildup. Has applications across many diseases.